日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy and safety of VPM1002 and Immuvac in preventing tuberculosis: phase 3 randomised clinical trial (PreVenTB trial)

VPM1002 和 Immuvac 预防结核病的有效性和安全性:3 期随机临床试验(PreVenTB 试验)

Singh, Manjula; Joshi, Sindhu; Vohra, Vikram; Sarin, Rohit; Kamble, Suchit Vasant; Velayutham, Banurekha; Mohan, Anant; Singh, Urvashi B; Kumar, Rakesh; Pati, Sanghamitra; Pattnaik, Manoranjan; Mohapatra, Prasanta Raghab; Shankar, Uma; Narasimhaiah, Somashekar; Yadav, Geeta; Hissar, Syed; Rodrigues, Rashmi; Kadam, Abhijit Vasantrao; Paramasivam, Paul Kumaran; Kambhampati, Sailaja; Newtonraj, Ariarathinam; Palaniappan, Natarajan Alangudi; Reddy, S Devarajulu; Bhuniya, Sourin; Mishra, Bijaya Kumar; Shete, Ashwini; Hanna, Luke Elizabeth; Mitra, Dipendra Kumar; Panda, Samiran; Guleria, Randeep; Tripathy, Srikanth; Roy, Neelam; D'Souza, George; Tripathy, S K; Katoch, Kiran; Pandey, Ravindra M; Sah, Seema; Kashyap, Manisha; Telasey, Vinay; Bakshi, Meenakshi; Wadhwa, Nitya; Khan, Abdul Mabood; Gangakhedkar, Raman R; Rani, Rajni

The Zika vaccine pursuit: Now is it the right time to act?

寨卡疫苗研发:现在是采取行动的合适时机吗?

Desai, Deepali; Ugale, Nikita; Bhawalkar, Jitendra; Tripathy, Srikanth Prasad; Khopkar-Kale, Priyanka

Effect of antiretroviral therapy on retention of people living with HIV in India (2012-2017): a retrospective, cohort study

抗逆转录病毒疗法对印度艾滋病毒感染者治疗依从性的影响(2012-2017 年):一项回顾性队列研究

Chidrawar, Shweta; Sane, Suvarna; Mamulwar, Megha; Bembalkar, Shilpa; Thakur, Rachna; Bhatnagar, Tarun; Tripathy, Srikanth P; Marinaik, Shrinivasa B; Sahu, Damodar; Biswas, Subrata; Datta, Shanta; Sabde, Yogesh; Tiwari, Rajnarayan; Khismatrao, Deepak; Kushwaha, Bhawani Singh; Puri, Anoop Kumar; Das, Chinmoyee; Godbole, Sheela V

Corrigendum to "Effect of antiretroviral therapy on retention of people living with HIV in India (2012-2017): a retrospective, cohort study," [The Lancet Regional Health Southeast Asia. Volume 34, 100552, March 2025]

对“抗逆转录病毒疗法对印度 HIV 感染者治疗依从性的影响(2012-2017 年):一项回顾性队列研究”的更正[《柳叶刀区域健康东南亚》,第 34 卷,100552,2025 年 3 月]

Chidrawar, Shweta; Sane, Suvarna; Mamulwar, Megha; Bembalkar, Shilpa; Thakur, Rachna; Bhatnagar, Tarun; Tripathy, Srikanth P; Marinaik, Shrinivasa B; Sahu, Damodar; Biswas, Subrata; Datta, Shanta; Sabde, Yogesh; Tiwari, Rajnarayan; Khismatrao, Deepak; Kushwaha, Bhawani Singh; Puri, Anoop Kumar; Das, Chinmoyee; Godbole, Sheela V

Phenotypic and genotypic characterization of Mycobacterium tuberculosis pyrazinamide resistance-India, 2018-2020

2018-2020年印度结核分枝杆菌吡嗪酰胺耐药性的表型和基因型特征

Tamilzhalagan, Sembulingam; Justin, Evanslin Santus; Selvaraj, Ashok; Venkateswaran, Karthick; Sivakumar, Arun Kumar; Chittibabu, Suganthi; McLaughlin, Heather P; Moonan, Patrick K; Smith, Jonathan P; Suba, Sakthi; Sathya Narayanan, Mukesh Kumar; Ho, Christine S; Kumar, Nishant; Tripathy, Srikanth P; Shanmugam, Siva K; Hall-Eidson, Patricia J; Ranganathan, Uma Devi

Humoral and cellular immune response to AZD1222 /Covishield and BV152/Covaxin COVID-19 vaccines among adults in India

印度成年人对AZD1222/Covishield和BV152/Covaxin新冠疫苗的体液和细胞免疫反应

Tripathy, Anuradha S; Singh, Dharmendra; Trimbake, Diptee; Salwe, Sukeshani; Tripathy, Srikanth; Kakrani, Arjun; Jali, Priyanka; Chavan, Hanmant; Yadav, Pragya; Sahay, Rima; Sarje, Prakash; Babar, Prasad; Shete, Anita; Nandapurkar, Ashok; Kulkarni, Milind

Monocyte to lymphocyte ratio and hemoglobin level to predict tuberculosis after antiretroviral therapy initiation

单核细胞与淋巴细胞比值和血红蛋白水平预测抗逆转录病毒治疗开始后结核病的发生

Gatechompol, Sivaporn; Kerr, Stephen J; Cardoso, Sandra W; Samaneka, Wadzanai; Tripathy, Srikanth; Godbole, Sheela; Ghate, Manisha; Kanyama, Cecilia; Nyirenda, Mulinda; Sugandhavesa, Patcharaphan; Machado, Andre; Van Leth, Frank; Campbell, Thomas B; Swindlells, Susan; Avihingsanon, Anchalee; Cobelens, Frank

T-cell responses in COVID-19 survivors 6-8 months after infection: A longitudinal cohort study in Pune

新冠肺炎幸存者感染后 6-8 个月的 T 细胞反应:一项在浦那进行的纵向队列研究

Suryawanshi, Poonam; Patil-Takbhate, Bhagyashri; Athavale, Prachi; Mirza, Shahzad; Tripathy, Anuradha; Kanitkar, Shubhangi; Shivnitwar, Sachin; Barthwal, Madhusudan S; Dole, Sachin; Chavan, Hanumant; Jali, Priyanka; Pawale, Sujata; Kakad, Dhanashree; Kakrani, Arjun Lal; Bhawalkar, Jitendra; Gandhi, Madhura; Chaturvedi, Sarika; Karandikar, Mahesh; Tripathy, Srikanth

PreVenTB trial: protocol for evaluation of efficacy and safety of two vaccines VPM1002 and Immuvac (Mw) in preventing tuberculosis (TB) in healthy household contacts of newly diagnosed sputum smear-positive pulmonary TB patients: phase III, randomised, double-blind, three-arm placebo-controlled trial

PreVenTB试验:评估两种疫苗VPM1002和Immuvac (Mw)预防新诊断痰涂片阳性肺结核患者健康家庭接触者感染结核病的有效性和安全性的方案:III期、随机、双盲、三组安慰剂对照试验

Singh, Manjula; Mehendale, Sanjay; Guleria, Randeep; Sarin, Rohit; Tripathy, Srikanth; Gangakhedkar, Raman R; Katoch, Kiran; Pandey, Ravindra Mohan; Panda, Samiran; Pati, Sanghamitra; Mohapatra, Prasanta Raghab; Joshi, Sindhu; Narasimhaiah, Somashekar; Kodan, Parul; Bhaskar, Sangeeta; Rani, Rajni; Khan, Abdul Mabood; Swaminathan, Soumya

Correction: Tuberculosis (TB) Aftermath: study protocol for a hybrid type I effectiveness-implementation non-inferiority randomized trial in India comparing two active case finding (ACF) strategies among individuals treated for TB and their household contacts

更正:结核病(TB)后续研究:一项在印度开展的混合型 I 类有效性-实施非劣效性随机试验的研究方案,该试验比较了两种针对结核病治疗患者及其家庭接触者的主动病例发现(ACF)策略。

Cox, Samyra R; Kadam, Abhay; Atre, Sachin; Gupte, Akshay N; Sohn, Hojoon; Gupte, Nikhil; Sawant, Trupti; Mhadeshwar, Vishal; Thompson, Ryan; Kendall, Emily; Hofmann, Christopher; Suryavanshi, Nishi; Kerrigan, Deanna; Tripathy, Srikanth; Kakrani, Arjunlal; Barthwal, Madhusudan S; Mave, Vidya; Golub, Jonathan E